[Staphylococcal pneumonia]

V Popescu1, D Dragomir

  • 1Clinica de Pediatrie, Spitalul Clinica St. Pantelimon, Bucureşti.

Pediatrie (Bucharest, Romania)
|January 1, 1991
PubMed

Insights

Staphylococcal pneumonia remains a severe childhood illness due to Staphylococcus virulence factors. Early diagnosis and comprehensive treatment, including antibiotics and pleural drainage, are crucial for managing this condition.

Area of Science:

  • Pediatric Infectious Diseases
  • Bacteriology
  • Pulmonology

Background:

  • Staphylococcal pneumonia is a severe childhood bacterial pneumonia.
  • Staphylococcus virulence factors contribute to its severity, including necrotizing capacity and antibiotic resistance.
  • It accounts for one-third of primitive bacterial pneumonias in children under two years old.

Purpose of the Study:

  • To review the etiology, epidemiology, pathogenesis, and pathology of staphylococcal pneumonia in children.
  • To analyze clinical, radiological, and laboratory findings for diagnosis.
  • To discuss treatment strategies, complications, and prognosis.

Main Methods:

  • Review of etiological, epidemiological, and pathogenesis data.
  • Analysis of clinical presentation, radiological findings, and laboratory results.
  • Discussion of diagnostic criteria, differential diagnoses, and treatment modalities.

Main Results:

  • Radiological examination is key, revealing rapidly changing lesions like pleurisy, pyopneumothorax, and abscesses.
  • Diagnosis relies on correlating medical history, clinical signs, imaging, and bacteriology.
  • Differential diagnosis includes other suppurative lung diseases and cystic lesions.

Conclusions:

  • Staphylococcal pneumonia requires prompt diagnosis and management.
  • Treatment involves antibiotics, pleural drainage, and supportive care.
  • Understanding its unique radiological features aids in early identification and management.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...